Related Experiment Video
Updated: Dec 16, 2025
Author Spotlight: A Novel Standardized Technique for Real-Time Biomedical Imaging of Acute Myocardial Injury
Published on: March 22, 2024
The ISCHEMIA trial: Implications for non-invasive imaging
Amina Rakisheva1, Mohamed Marwan1, Stephan Achenbach1
1Department of Cardiology, Friedrich Alexander University Erlangen-Nürnberg (FAU); Erlangen-Germany.
Insights
The ISCHEMIA trial found no difference in hard outcomes between conservative treatment and immediate revascularization for coronary artery disease (CAD). However, revascularization provided more effective angina relief in patients with moderate to severe ischemia.
Area of Science:
- Cardiology
- Clinical Trials
- Diagnostic Imaging
Background:
- Coronary artery disease (CAD) is a leading cause of global mortality.
- Diagnosing CAD presents challenges, with current methods focusing on ischemia detection or stenosis visualization.
- Treatment strategies include medical management and revascularization.
Purpose of the Study:
- To explore the implications of the ISCHEMIA trial for non-invasive testing in suspected CAD.
- To analyze the outcomes of patients with moderate to severe ischemia treated conservatively versus with immediate revascularization.
Main Methods:
- The ISCHEMIA trial randomized patients with moderate to severe ischemia (and no left main stenosis) to conservative treatment or immediate revascularization.
- Diagnostic approaches included functional stress tests and stenosis visualization via CT angiography or invasive angiography.
Main Results:
- No significant difference in hard clinical outcomes was observed between the conservative and revascularization groups.
- Patients undergoing immediate revascularization reported more effective relief from angina symptoms.
Conclusions:
- The ISCHEMIA trial provides crucial insights into managing stable ischemic heart disease.
- Findings suggest a re-evaluation of the role and interpretation of non-invasive stress testing in CAD diagnosis and treatment guidance.
Abstract:
Coronary artery disease (CAD) is highly prevalent and constitutes the single most common cause of death worldwide. However, the diagnosis of CAD remains challenging. There are two ways to approach the diagnosis of CAD, namely (1) by a functional non-invasive stress test to detect ischemia (stress echocardiography, stress cardiovascular magnetic resonance, single-photon emission computed tomography, positron emission tomography) or (2) by imaging for stenosis visualization (coronary computed tomography angiography or invasive coronary angiography). There are also two approaches for treatment: medical treatment and revascularization. The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial investigated the outcome differences of patients who had moderate to severe ischemia on stress testing and who, after CT angiography, had ruled out left main stenosis and demonstrated at least 1 coronary artery stenosis exceeding 50%. The patients were randomized to an initially conservative treatment versus immediate revascularization. No difference in hard outcomes was found, but angina relief was more effective in the revascularization group. In this article, we explore the implications of the ISCHEMIA trial for non-invasive testing in suspected CAD.
